Sector: Pharmaceuticals

Featured in The Trademark Litigation Review 2024

As highlighted by multiple CJEU, Supreme Court and Federal Patent Court judgments, creating a valid registration, the scope of protection, justifications for non-use of trademarks and objections to registration of infringing marks are among the most pressing issues when it comes to litigating pharmaceutical trademarks in Germany.

24 November 2023

Featured in Stock market performance

The WTR Brand Elite fell two points in October, hitting its lowest value this year. Yet technology companies – led by Microsoft – bucked the negative trend.

17 November 2023

The decision provides some clarity on the extent to which EUTM owners may rely on the principles of the protection of legitimate expectations and legal certainty.

03 November 2023

Featured in Stock market performance

The WTR Brand Elite fell seven points in September, hitting its lowest value since 1 January 2023. However, the brands that experienced the biggest drop in value have reason to remain optimistic.

30 October 2023

The General Court confirmed that there was no likelihood of confusion between Novartis’ mark PASCELMO and the earlier mark PASCOE, both covering Class 5 goods.

27 October 2023

A key finding was that the word ‘kind’ is not commonly used in the pharmaceutical industry and is not descriptive of pharmaceutical products.

24 October 2023

As the deadline to nominate for the 2024 WTR Industry Awards approaches, our Saturday opinion column discusses why it is paramount for IP departments to promote themselves as their own brand.

21 October 2023

Data analysis reveals the companies with the largest trademark portfolios in the Association of Southeast Asian Nations – and evolving trends among the most active filers.

16 October 2023

As Novo Nordisk and Eli Lilly work overtime to meet soaring demand for their popular diabetes and obesity drugs, trademark experts weigh in on what brand owners can do when opportunists take advantage of supply issues.

12 October 2023

We continue our latest series of pieces highlighting Legal Updates that you may have missed by looking at recent guidance by the EU General Court on what constitutes genuine use of an EU trademark.

03 October 2023